title: Eye Conditions in Older Adults: Age-Related Macular Degeneration.
abstract: Age-related macular degeneration (AMD) causes a progressive loss of photoreceptors in the macula. It is the most common cause of legal blindness in the United States, and some form of AMD is thought to affect more than 9 million individuals. Risk factors include older age, smoking, dyslipidemia, obesity, white race, female sex, and a family history of AMD. There are two types of advanced AMD: nonexudative (dry or geographic atrophy) and exudative (wet or neovascular). Both cause progressive central vision loss with intact peripheral vision. Nonexudative AMD accounts for 80% to 90% of all advanced cases, and more than 90% of patients with severe vision loss have exudative AMD. On ophthalmoscopic examination, early findings include drusen (ie, yellow deposits in the retina). Prominent choroidal vessels, subretinal edema, and/or hemorrhage are seen in wet AMD. Regular eye examinations, visual field testing, fluorescein angiography, and optical coherence tomography are used for diagnosis and to guide management. There is no specific therapy for dry AMD, but antioxidant supplementation may be helpful. Intravitreal injection of a vascular endothelial growth factor inhibitor is the treatment of choice for wet AMD. Optical aids and devices can help to maximize function for patients with AMD.
authors.affiliation: Department of Family Medicine Hofstra North Shore LIJ School of Medicine Southside Hospital, 301 East Main Street Bay Shore, NY 11706.
authors.forename: Tochi
authors.initials: T
authors.lastname: Iroku-Malize
authors.affiliation: Department of Family Medicine Hofstra North Shore LIJ School of Medicine Southside Hospital, 301 East Main Street Bay Shore, NY 11706.
authors.forename: Scott
authors.initials: S
authors.lastname: Kirsch
mesh_terms: D000368:Aged; D000375:Aging; D006801:Humans; D008268:Macular Degeneration / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D008297:Male